Cold Pain Therapy is also known as cryotherapy which comprises the use of cold materials for pain management in orthopedic conditions, soft tissue injuries, and musculoskeletal disorders. Cold pain therapy reduces the blood flow to the affected area which helps in the reduction of pain, swelling, and inflammation.
The cold pain therapy market is majorly comprised of top players involving Brownmed Inc, Bruder Healthcare Co LLC, DJO Global Inc, Ossur hf, Cardinal Health Inc, Vive Health LLC, Battle Creek Equipment Co, ThermoTek Inc, Advanced Therapeutics of LI LLC, Sichuan Jiuyuan Medical Technology Co Ltd.
The global cold pain therapy market is expected to reach US$ 3,143.88 million by 2028; registering at a CAGR of 5.3% from 2022 to 2028, according to a new research study conducted by The Insight Partners.
The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the Cold Pain Therapy market:
| Year | News |
| Sep-2019 | DJO, Global Inc. announced the launch of the new DonJoy IceMan CLASSIC3 cold therapy unit that helps reduce pain and swelling through controlled delivery of extended cold therapy. |
| Feb-2021 | Breg, Inc. has partnered with Australian-based distributor Club Warehouse to expand delivery of its premium, high-value orthopedic products in the Australian market including cold pain therapy products. The company offer its products to orthopedic practices and sports organizations across the continent, including the Australian Football League (AFL), National Rugby League (NRL) and Rugby Union Clubs. |
